Literature DB >> 2297216

Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor.

H L Chin, D A Buchan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2297216     DOI： 10.7326/0003-4819-112-4-312_2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  12 in total

1.  Angioedema due to ACE inhibitors: increased risk in patients of African origin.

Authors:  C R Gibbs; G Y Lip; D G Beevers
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

2.  Severe migratory Angioedema due to ACE inhibitors use.

Authors:  G Peltekis; D Palaskas; M Samanidou; A Fragakis; K Alexopoulos; A Kotsani; I Vogiatzis; E Kyrmizakis
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

3.  Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.

Authors:  T Hedner; O Samuelsson; H Lunde; L Lindholm; L Andrén; B E Wiholm
Journal:  BMJ       Date:  1992-04-11

4.  [Life-threatening swelling of the tongue in antihypertensive therapy with ACE inhibitors].

Authors:  A Brandes; R Bschorer; G Gehrke; G Kessler; R Schmelzle
Journal:  Mund Kiefer Gesichtschir       Date:  1997-02

5.  Severe angioedema and respiratory distress associated with lisinopril use.

Authors:  G W Soo Hoo; H T Dao; W B Klaustermeyer
Journal:  West J Med       Date:  1993-04

6.  Bad gut feeling: ACE inhibitor induced intestinal angioedema.

Authors:  Oliver Weingärtner; Nadja Weingärtner; Michael Böhm; Ulrich Laufs
Journal:  BMJ Case Rep       Date:  2009-02-27

Review 7.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

8.  Angiotensin-converting enzyme inhibitors and angioedema.

Authors:  Mario Sánchez-Borges; Luis A González-Aveledo
Journal:  Allergy Asthma Immunol Res       Date:  2010-05-06       Impact factor: 5.764

Review 9.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

10.  Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.

Authors:  R Cirillo; A R Renzetti; P Cucchi; M Guelfi; A Salimbeni; S Caliari; A Castellucci; S Evangelista; A Subissi; A Giachetti
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.